Clinical Trial Update: Changes in PACAP, CGRP, and VIP Levels in Rosacea Patients on Systemic Isotretinoin and Their Association with Erythema [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating changes in neuropeptides (PACAP, CGRP, VIP) in rosacea patients treated with systemic isotretinoin and their association with erythema.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rosacea

Drugs mentioned

• ISOTRETINOIN (Isotretinoin)

Snippet

Sponsor: SB Istanbul Education and Research Hospital | Conditions: Rosacea | Phase 4 | Status: COMPLETED